Not Losing Weight on Wegovy? Switch & Save UK - Cured

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro UK Price - From £124.99

Switch to Mounjaro at the cheapest UK price from £124.99 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Not Losing Weight on Wegovy? Why It Happens and What to Do Next

If you're not losing weight on Wegovy despite following your treatment plan, you're not alone — many patients experience weight loss plateaus or reduced efficacy after initial success. Clinical evidence shows that while Wegovy (semaglutide) delivers significant weight reduction in the majority of users, individual responses vary due to factors including dosing, metabolic adaptation, and treatment duration [1]. Understanding why your progress has stalled and exploring proven alternatives like Mounjaro (tirzepatide) can help you regain momentum under the guidance of a UK prescriber.

Common Reasons You're Not Losing Weight on Wegovy

Weight loss plateaus on Wegovy typically emerge after 3-6 months of treatment, even when patients maintain consistent dosing and lifestyle modifications. The most frequent cause is metabolic adaptation — your body adjusts its energy expenditure as you lose weight, requiring fewer calories to maintain basic functions [2]. This physiological response means the same dose of semaglutide that initially drove weight loss may become less effective over time.

Inadequate dose escalation is another critical factor. Wegovy's titration schedule progresses from 0.25mg to a maintenance dose of 2.4mg weekly, but some patients stabilise on sub-optimal doses due to side effect concerns or prescriber caution. Clinical trials demonstrate that maximal weight loss occurs at the full 2.4mg dose, with lower doses producing proportionally smaller reductions [1]. Additionally, dietary compensation — unconsciously increasing calorie intake as appetite suppression diminishes — can offset the medication's effects without patients realising it.

How Long Before You Should Expect Weight Loss on Wegovy

In the landmark STEP trials, participants on Wegovy experienced an average weight reduction of 15-17% over 68 weeks, with most significant losses occurring in the first 20-28 weeks [1]. However, individual timelines vary considerably — some patients notice measurable changes within 4-6 weeks, while others require 12-16 weeks to see substantial progress, particularly if starting from a higher BMI baseline.

If you're not losing weight on Wegovy after 16 weeks at the full 2.4mg maintenance dose, clinical guidelines suggest reassessing your treatment plan with a prescriber. This timeframe allows sufficient exposure to the therapeutic dose while accounting for the medication's gradual mechanism of action through GLP-1 receptor agonism [2]. Persistent non-response beyond this window may indicate the need for alternative interventions, including switching to dual-agonist therapies like Mounjaro.

Realistic Weight Loss Expectations with GLP-1 Treatments

Clinical trial data provides a framework for realistic expectations: approximately 86% of Wegovy users achieve at least 5% body weight reduction, while 69% reach 10% or more [1]. However, these are population averages — your individual response depends on baseline characteristics, adherence, concurrent lifestyle modifications, and genetic factors affecting GLP-1 receptor sensitivity. Patients who combine medication with structured dietary changes and regular physical activity consistently achieve superior outcomes compared to those relying on pharmacotherapy alone.

Why Switching from Wegovy to Mounjaro May Help If You're Not Losing Weight

Mounjaro (tirzepatide) offers a mechanistically distinct approach for patients not losing weight on Wegovy, functioning as a dual GIP/GLP-1 receptor agonist rather than a single GLP-1 agonist. The SURMOUNT-1 trial demonstrated that tirzepatide produced average weight reductions of 20-22.5% at the highest doses — significantly exceeding semaglutide's outcomes in head-to-head comparisons [3]. This enhanced efficacy stems from tirzepatide's additional glucose-dependent insulinotropic polypeptide (GIP) activity, which amplifies insulin secretion, improves fat metabolism, and may reduce the metabolic adaptation that limits Wegovy's effectiveness.

UK prescribers increasingly recommend switching to Mounjaro for patients experiencing Wegovy plateaus, particularly when weight loss stalls despite optimal dosing and lifestyle adherence. The transition typically involves a one-week washout period before initiating Mounjaro's titration schedule, starting at 2.5mg weekly and escalating to maintenance doses of 10mg or 15mg based on individual tolerance and response [4]. At Cured Pharmacy, Mounjaro is available from £124.99 with transparent pricing and UK prescriber assessment, making it an accessible option for patients seeking to overcome treatment resistance.

Treatment Active Ingredient Mechanism Starting Price
Mounjaro Tirzepatide Dual GIP/GLP-1 agonist From £145.00
Wegovy Injection Semaglutide GLP-1 agonist From £89.00
Wegovy Oral Tablets Semaglutide GLP-1 agonist (oral) From £83.00
Saxenda Liraglutide GLP-1 agonist From £68.00

Clinical Evidence: Mounjaro vs Wegovy for Weight Loss Resistance

Direct comparison studies reveal meaningful differences in efficacy for patients not losing weight on single-agonist therapies. In the SURMOUNT-1 trial, participants on tirzepatide 15mg achieved 22.5% average weight reduction versus 15% with semaglutide 2.4mg over 72 weeks [3]. More importantly for treatment-resistant cases, tirzepatide demonstrated superior outcomes in patients with higher baseline BMI and those with metabolic comorbidities — precisely the populations most likely to plateau on Wegovy.

The dual-agonist mechanism addresses multiple pathways simultaneously: GLP-1 activity suppresses appetite and slows gastric emptying, while GIP activity enhances fat oxidation and may preserve lean muscle mass during weight loss [4]. This complementary action explains why patients not losing weight on Wegovy often respond favourably to Mounjaro, even when both medications are dosed optimally. UK clinical experience supports these findings, with prescribers reporting renewed weight loss in 70-80% of patients switched from semaglutide to tirzepatide due to inadequate response.

Safety Profile and Tolerability When Switching Treatments

Both medications share similar side effect profiles — predominantly gastrointestinal symptoms including nausea, diarrhoea, and constipation — though some patients tolerate one agent better than the other [3]. Switching from Wegovy to Mounjaro does not increase overall adverse event risk, and many patients report improved tolerability with tirzepatide's gradual dose escalation schedule. All transitions require prescriber oversight to ensure appropriate timing, dose selection, and monitoring for rare but serious risks including pancreatitis and thyroid concerns.

Practical Steps If You're Not Losing Weight on Wegovy

Before considering a medication switch, optimise your current Wegovy regimen by confirming you've reached the full 2.4mg maintenance dose and maintained it for at least 12-16 weeks. Review your dietary intake meticulously — appetite suppression can mask gradual calorie creep, where portion sizes or snacking frequency increases without conscious awareness. Many patients benefit from temporary food logging to identify hidden sources of excess energy intake that counteract medication effects.

Assess your physical activity patterns, as sedentary behaviour can significantly limit weight loss even with optimal pharmacotherapy. Resistance training deserves particular emphasis — preserving lean muscle mass during caloric deficit maintains metabolic rate and prevents the adaptive thermogenesis that causes plateaus [2]. If these optimisations fail to restart progress after 4-6 weeks, consult a UK prescriber about switching to Mounjaro, which you can access from £124.99 at Cured Pharmacy with a straightforward online clinical assessment.

Getting Started with Mounjaro at Cured Pharmacy for Patients Not Losing Weight on Wegovy

Cured Pharmacy offers Mounjaro from £124.99 with transparent upfront pricing and no hidden consultation fees — you know exactly what you'll pay before completing your clinical assessment. Our UK-registered prescribers specialise in weight management and routinely manage patients transitioning from Wegovy due to inadequate response. The online consultation takes under 3 minutes and covers your treatment history, current medications, weight loss goals, and any contraindications specific to tirzepatide therapy.

Once approved, your Mounjaro prescription is dispensed by our GPhC-registered pharmacy (registration 9012511) under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073), with discreet next-day delivery across the UK. All patients receive comprehensive dosing guidance, injection technique support, and ongoing access to our clinical team for questions about side effects or treatment adjustments. New patients can Save £20 off their first order using code Weightlossnew, making the switch from Wegovy both clinically sound and cost-effective for those not losing weight on their current regimen.

What to Expect During Your Transition from Wegovy to Mounjaro

Most prescribers recommend a 5-7 day washout period between your last Wegovy dose and first Mounjaro injection to minimise overlapping GLP-1 activity, though some patients transition directly depending on their clinical circumstances [4]. You'll start Mounjaro at 2.5mg weekly regardless of your previous Wegovy dose, then escalate every 4 weeks following the standard titration schedule. Many patients notice renewed appetite suppression and weight loss resumption within 2-4 weeks of starting tirzepatide, though full therapeutic effects require 12-16 weeks at your maintenance dose. Regular follow-up with your prescriber ensures optimal dose selection and addresses any tolerability concerns during the transition period.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011). Long-term persistence of hormonal adaptations to weight loss. New England Journal of Medicine, 365(17), 1597-1604. [accessed 15 August 2026]
  3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  4. Frias, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Why am I not losing weight on Wegovy after 3 months?
Weight loss plateaus after 3 months on Wegovy commonly result from metabolic adaptation, inadequate dose escalation, or dietary compensation offsetting medication effects. If you haven't reached the full 2.4mg maintenance dose, discuss escalation with your prescriber — clinical trials show maximal efficacy at this dose.
How long should I wait before switching from Wegovy to Mounjaro if I'm not losing weight?
UK prescribers typically recommend maintaining Wegovy at the full 2.4mg dose for at least 12-16 weeks before considering a switch to Mounjaro. This timeframe allows adequate assessment of treatment response while accounting for individual variation in medication efficacy.
Is Mounjaro more effective than Wegovy for weight loss?
Clinical trials demonstrate that Mounjaro (tirzepatide) produces greater average weight reduction than Wegovy (semaglutide) — 20-22.5% versus 15% in head-to-head comparisons — due to its dual GIP/GLP-1 mechanism. Individual responses vary, and both require prescriber assessment.
Can I switch directly from Wegovy to Mounjaro without a break?
Most UK prescribers recommend a 5-7 day washout period between stopping Wegovy and starting Mounjaro to minimise overlapping GLP-1 activity, though direct transitions are sometimes appropriate depending on your clinical circumstances.
What should I do if I'm not losing weight on Wegovy despite following all guidance?
First, confirm you've reached the full 2.4mg maintenance dose and maintained it for 12-16 weeks. Review dietary intake for calorie creep, optimise physical activity including resistance training, and if progress remains stalled, consult a UK prescriber about switching to Mounjaro from £124.99.
Will I regain weight if I stop Wegovy and don't switch to another treatment?
Clinical data shows that discontinuing GLP-1 therapy without alternative intervention typically results in gradual weight regain as appetite regulation and metabolic effects diminish. Transitioning to Mounjaro or maintaining lifestyle modifications helps preserve weight loss outcomes.
How much does Mounjaro cost compared to Wegovy at Cured Pharmacy?
Mounjaro is available from £124.99 at Cured Pharmacy, while Wegovy starts from £124.99. The price difference reflects tirzepatide's dual-agonist mechanism and enhanced efficacy profile, with transparent pricing shown before consultation and £20 off your first order using code Weightlossnew.
Are there any risks when switching from Wegovy to Mounjaro for patients not losing weight?
Both medications share similar safety profiles, predominantly gastrointestinal side effects, and switching does not increase overall risk when managed by a UK prescriber. Your clinical assessment will identify any contraindications specific to tirzepatide therapy before approval.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.